Results: Of 60 eligible patients, 50 consented to participate. Of 1473 esophageal specimens
obtained at 5 years 85% contained lamina propria or deeper tissue (per patient, mean 30 …

Barrett's esophagus (BE) is the precursor for esophageal adenocarcinoma (EAC). The risk of
progression from nondysplastic BE (NDBE) to EAC is 30-fold to 125-fold greater than in the …

Methods Patients with a 2-15 cm BE with low-grade dysplasia (LGD), high-grade dysplasia
(HGD) or early cancer (EC) were included. Visible lesions were removed by endoscopic …

Background Endoscopic eradication therapy with radiofrequency ablation (RFA) is effective
in most patients with Barrett's esophagus (BE). However, some patients experience poor …

Background and aims Endoscopic mucosal resection (EMR) and radiofrequency ablation
(RFA) for Barrett's esophagus (BE)-related high-grade dysplasia (HGD) and early …

Because of the morbidity and mortality that may be associated with esophagectomy, less
invasive endoscopic treatment modalities have emerged to treat high− grade dysplasia …

Barrett's oesophagus is the only know pre-cursor to oesophageal adenocarcinoma. The
incidence of OAC is growing rapidly in the western world with a poor prognosis for most with …

Barrett's esophagus (BE) is defined as a metaplastic change in the normal esophageal
squamous epithelium to an intestinalized columnar epithelium, likely in response to chronic …

Barrett's esophagus is a condition in which the normal squamous lining of the esophagus
has been replaced by columnar epithelium containing intestinal metaplasia induced by …

Background & Aims After radiofrequency ablation (RFA), patients may experience
recurrence of Barrett's esophagus (BE) after complete eradication of intestinal metaplasia …